Using Ivermectin as a Backup to Conventional Cancer Treatment

Last Updated on November 2, 2024 by Primary Researcher

Executive Summary

• This article covers the importance of considering the probability that the recommended cancer treatment is either not working or is not tolerated.

Introduction

Something that most cancer patients don’t consider is that they will not be able to tolerate their conventional cancer treatment. This article explains why it is essential to have a backup plan for the very high percentage of cases where conventional cancer treatment does not work or is not tolerated. 

Case Study of Discontinuing a Conventional Cancer Treatment

The following quotes are information shared with us by a subscriber. This subscriber is describing his mother, who is a cancer patient. This is an example of a patient who was not able to continue their conventional cancer treatment.

The Patient Experiences a Major Supraventricular Tachycardia Event from the Chemotherapy Drug Cisplatin

Two days later, while waiting the bus, her heart beat went quite high again, although this time she literally had her eyes left in total white, her lips went inside her mouth. She completely disconnected physically. I was with her, I literally screamed to people for an ambulance. They took her to emergencies and stabilized her..no one could tell what it was.

That same day, I found this article below, which relates how the Cisplatin in a patient with Breast Cancer would trigger Supraventricular Tachycardia:

“Cisplatin chemotherapy, on the other hand, is linked to cardiotoxicity, which may vary from silent arrhythmias to heart failure to sudden cardiac death. In this article, we describe a case of supraventricular tachycardia induced by cisplatin in a breast cancer patient.”

Cisplatin is highly connected to cardiotoxicity.

A significant way that oncologists obtain conformance to their recommended treatments is by understating or simply omitting the side effects. Then, when the side effect occurs, the patient and their family are told that the side effect is “very rare” when it is not at all rare. This allows the Oncologist to enforce treatment conformance and look like no one could have predicted the side effects.

The Recommendation for Treatment Continuation

The article mentioned the patient didn’t have heart conditions prior to the Cisplatin (same situation as my mother, never in her life had heart issues). I demanded a Cardiologist to see my mother. They were reluctant until I finally managed to get the booking.

I was present with her during this appointment. I told the cardiologist about this same article. The cardiologist seemed somewhat offended as if I was some sort of guy trying to seem to “know more” on the issue, so he never gave me eye contact, and always directed his sight to my mom, saying that her heart was ok and that she should continue with treatment due to her serious condition.

This type of response from this cardiologist is extremely common.

Our Previous Experiences With Oncologists

In case after case, when our subscribers have told their oncologists of their side effects or that their chemotherapy dosage is too high, the oncologist will tell the patient to continue at the dosage initially recommended. Secondly, the problem with seeing a second MD is that MDs of other specialties (in this case, cardiology) are extremely unlikely to recommend a change to the treatment of another MD. There is a type of professional courtesy where one MD will not contradict another MD — even in cases where it will lead to a negative outcome for the patient. That is, MDs are very sensitive to “stepping on the toes” of other MDs.

Finally, the statement that the patient’s heart was “ok” might be true, depending upon what this statement means. This heart is probably fine or at least sufficient under normal conditions, but it obviously has a very serious complication from the dosage level of Cisplatin. That is a person’s organ functioning can be fine, but unable to tolerate a treatment.

What Should Be The Real Question?

The question is not how the organ functions in an unmolested fashion but whether the organ is functional under the influence of a treatment. The way this cardiologist answered this question made it unclear which of the two topics he is addressing with this answer. 

If a patient nearly dies from a drug, there needs to be a discussion of either terminating the treatment or reducing the dosage. That is something that has to change. However, I don’t see this discussed in any way in this description from the subscriber. One does not need any specialized knowledge to figure this out.

Ceasing Chemotherapy

I did not take her to chemo that week. So, I let her skip the last session. Long story short, they stopped the treatment, they did not give the brachytherapy to my mother, and they gave her a pen and paper to surrender the treatment.

It seems like this chemotherapy would be classified as “palliative chemotherapy.” This is chemotherapy used in cases where there is no potential for a cure. I cover the illogic of palliative chemotherapy in the article How Cancer Centers Lie About the Definition of Palliative Care.

However, the short version of this is, is that no conventional treatment should be followed unless the treatment is “curative.” There are major negative consequences to all of the traditional cancer treatments. That is, you are required to give up a part of your health to obtain the potential for a cure for cancer. Without this potential, there is no point in accepting the negative consequences of conventional cancer treatments.

The Importance of a Backup Plan

It is important to remember that oncologists typically provide no backup plan if the recommended treatment (which is increasingly a combination of treatments—chemo, immunotherapy, radiation, etc.) is not practical or tolerated. Even under conditions where the patient is reacting negatively to the treatment, and in cases where the patient is being overdosed, it is extremely rare for even the dosage to be changed.

Conclusion

Most cancer patients begin their conventional cancer treatment with no backup plan. They assume that they won’t get into complications or that they will be able to complete the treatment. Dangerous complications are not occasional, they are ubiquitous with all of the conventional cancer treatments. This is why its important to have a backup plan when one is beginning a conventional cancer treatment. The oncologist will not offer a change in treatment, and all cancer patients need to be in a position to be able to discontinue their cancer treatments if necessary. Ivermectin and the other items we cover at this site are an excellent backup plan.